Oryzon to join the IBEX Small Cap Index
MADRID, SPAIN and CAMBRIDGE MA.
• The inclusion will become effective on December 24th
Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that the Technical Advisory Committee of the IBEX INDICES has decided to incorporate Oryzon to the Ibex Small Cap Index together with other five small-cap companies. This change will take effect as of December 24. The index adjustment will be made at the closing of the session on Friday 21.